Armstrong MJ, Okanoue T, Sundby Palle M, Sejling AS, et al. Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: Post hoc analysis of three randomised controlled trials. Diabetes Obes Metab 2024 Nov 28. doi: 10.1111/dom.16065.
PMID: 39609879